MGC Pharmaceuticals: Developing a COVID treatment 
Listen to ASX-listed MGC Pharmaceuticals VP of International Relations Ron Lipsky talk to Matt Birney on the Bulls N’ Bears Report about the latest developments in MGC’s quest to develop a treatment for COVID-19.See <a href="https://omnystudio.com/listener">omnystudio.com/listener</a> for privacy information.

MGC Pharmaceuticals: Developing a COVID treatment Listen to ASX-listed MGC Pharmaceuticals VP of International Relations Ron Lipsky talk to Matt Birney on the Bulls N’ Bears Report about the latest developments in MGC’s quest to develop a treatment for COVID-19. See omnystudio.com/listener for privacy information.

MGC Pharmaceuticals: Developing a COVID treatment 
Listen to ASX-listed MGC Pharmaceuticals VP of International Relations Ron Lipsky talk to Matt Birney on the Bulls N’ Bears Report about the latest developments in MGC’s quest to develop a treatment for COVID-19.See <a href="https://omnystudio.com/listener" rel="noopener noreferrer">omnystudio.com/listener</a> for privacy information.

Bulls N’ Bears – MGC Pharmaceuticals (VP interview – COVID-19 treatment development)

Matt Birney and Bulls N' Bears sit at the epicentre of the small cap ASX-listed company space in Perth and Western Australia. Bulls N&rsquo; Bears covers public company news, views and CEO interviews across a number of main stream media platforms in WA. Its financial markets followers, who come from all four corners of the globe, are looking to zero in on Western Australia&rsquo;s unique international status as the most prolific developer of small capped publicly listed companies in the world.

Business

Investing

Matt Birney and Bulls N' Bears sit at the epicentre of the small cap ASX-listed company space in Perth and Western Australia. Bulls N’ Bears covers public company news, views and CEO interviews across a number of main stream media platforms in WA. Its financial markets followers, who come from all four corners of the globe, are looking to zero in on Western Australia’s unique international status as the most prolific developer of small capped publicly listed companies in the world.

Matt Birney and Bulls N' Bears sit at the epicentre of the small cap ASX-listed company space in Perth and Western Australia. Bulls N’ Bears covers public company news, views and CEO interviews across a number of main stream media platforms in WA. Its financial markets followers, who come from all four corners of the globe, are looking to zero in on Western Australia’s unique international status as the most prolific developer of small capped publicly listed companies in the world.

Share Bulls N’ Bears – MGC Pharmaceuticals (VP interview – COVID-19 treatment development)

Sign up to save your podcasts

Bulls N’ Bears – MGC Pharmaceuticals (VP interview – COVID-19 treatment development)

Bulls N’ Bears – MGC Pharmaceuticals (VP interview – COVID-19 treatment development)

More shows like Bulls N' Bears with Matt Birney

AFL Trade Radio

NAB Morning Call

Equity Mates Investing Podcast

Australian Investors Podcast

Money of Mine

The Explorers Podcast with Barry FitzGerald

Buy Hold Sell, by Livewire Markets

The Call from ausbiz

Market Updates

Footy Classified